White Paper: Pharma IQ Logistics Report

Why digital transformation is essential in the pharma supply chain

Published:

Sign up for the Controlant newsletter

Keep up with developments in pharma supply chain visibility. Sign up for Controlant Insights and receive our latest white paper.

The Covid-19 pandemic exposed the weaknesses in global pharmaceutical supply chains when it caused governments to shut their borders and manufacturing plants to close. Existing problems such as shortages of generic drugs and logistical and regulatory challenges hindered the ability of many organizations to quickly recover from disruptions.

This report covers the following:

How the pandemic impacted supply chains globally, exacerbating existing difficulties
The value of real-time monitoring tools
How digital transformation leads to more resilient supply chains

Read the free to download Pharma IQ Report

Insight

Disrupting the pharma supply chain with IoT

In their keynote at LogiPharma EU in April 2025, Gísli Herjólfsson (Controlant Co-CEO) and Dino Liquito (Global Logistics Business Partner at Roche) discussed the impact of disruptive technology, such as the Saga Card, and shared insights into the urgency of implementing real-time visibility, with IoT already transforming end-to-end supply chain configuration and transparency.

Insight

How to avoid 16,700t CO2e – a case study with Controlant and Vodafone

A groundbreaking case study conducted by the Carbon Trust, in collaboration with Controlant and Vodafone, highlights the transformative potential of real-time monitoring in pharmaceutical supply chains.

Insight

LogiPharma US 2024 key takeaways: the triple bottom line of pharma supply chain visibility

How do the most forward-thinking companies and brightest minds use technology to address the triple bottom line – patient, planet, profit – and prepare for the future of the pharma supply chain? This question permeated many of the conversations and presentations at LogiPharma US this year.